PharmiWeb.com - Global Pharma News & Resources

Company Directory - Clinical Research

Synexus, Acurian, and Optimal are now AES. AES owns the most fully identified patient data. And we own the world’s largest network of clinical research sites.
ASLAN Pharmaceuticals is a clinical-stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.
Our mission is to consistently deliver excellent quality and perfect-for-purpose chemistry solutions, from lead optimisation through product launch and life-cycle management, to enable our customers to create the best innovative therapeutics.
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 200 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise.
Domainex is a leading integrated medicines research service partner working with ambitious life science organisations from around the globe.
Our company offers support services to companies that work in the pharmaceutical industry. Why is it in your best interest to choose us? We can either serve you as a service provider of a whole project or just help you in pieces of work when your staff is overloaded with tasks. You choose the scenario of the co-operation.
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease. Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders. Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States.
PHASTAR is a global CRO offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP style arrangements and preferred partnerships.
Founded in 2015 Teckro provides solutions to simplify and modernise clinical research for leading pharmaceutical and emerging biotech companies.